Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Roche Gazyva application accepted by USFDA for lupus nephritis

Written By Ruchika Sharma5 March 2025 1:45 PM IST

Gazyva/Gazyvaro is an anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a CRR benefit in lupus nephritis.

Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority Nod

Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs

Written By Ruchika Sharma5 March 2025 11:30 AM IST

Bangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...

Bayer new drug application for gadoquatrane accepted for review in China

Bayer begins Phase II trial with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumors

Written By Ruchika Sharma5 March 2025 9:00 AM IST

Berlin: Bayer has announced that the first patient has been enrolled in the global Phase II panSOHO study, an open-label clinical trial,...

Zydus to develop typhoid-shigellosis vaccine for children

Zydus to make typhoid-shigellosis vaccine for children

Written By Ruchika Sharma4 March 2025 2:30 PM IST

Ahmedabad: Global lifesciences company, Zydus Lifesciences Limited, has announced the development of a combination vaccine against...

USFDA accepts GSK depemokimab applications for review for asthma, chronic rhinosinusitis

Written By Ruchika Sharma4 March 2025 12:30 PM IST

London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application for the use of...

AstraZeneca Faces NPPA Heat Over Symbicort Pricing, Slapped Rs 60 Crore Showcause Notice

AstraZeneca Imfinzi based perioperative regimen recommended for approval in EU for resectable non-small cell lung cancer

Written By Ruchika Sharma4 March 2025 10:15 AM IST

AstraZeneca has announced that Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for...

AstraZeneca to Invest USD 15 Billion in China by 2030

CDSCO nod to AstraZeneca Pharma India to import, sell lung cancer treatment medicine

Written By Ruchika Sharma3 March 2025 4:26 PM IST

AstraZeneca Pharma India has announced that the Company has received permission from the CentralDrugs Standard Control Organisation, Directorate...

Bayer Finerenone approved in Japan for chronic heart failure

Bayer-BlueRock Therapeutics bags USFDA Fast Track Designation for primary photoreceptor diseases treatment

Written By Ruchika Sharma3 March 2025 2:30 PM IST

Berlin: Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, has announced that...

Pharma, Healthcare Firms Set for 11% Growth in Q4, Margins Under Pressure: HDFC Securities

Glenmark US arm recalls 15 lakh bottles of ADHD medication in US

Written By Ruchika Sharma3 March 2025 1:10 PM IST

New Delhi: Glenmark Pharmaceuticals Inc, USA, an arm of the Mumbai-based Glenmark Pharmaceuticals, is recalling around 14.76 lakh bottles of...

CDSCO Delegates Veterinary Drug Licensing Powers to Zonal Offices to Ease Approvals

AstraZeneca-Daiichi Sankyo Enhertu recommended for approval in EU for patients with HER2-low or HER2-ultralow metastatic breast cancer

Written By Ruchika Sharma3 March 2025 12:15 PM IST

Cambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

Unichem Labs Pithampur API facility gets 4 USFDA observations

Written By Ruchika Sharma3 March 2025 11:30 AM IST

Mumbai: Unichem Labs has announced that the United States Food and Drug Administration (USFDA) has concluded an inspection with four observations...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis oral Fabhalta receives positive EMA Committee opinion for adults with C3 glomerulopathy

Written By Ruchika Sharma3 March 2025 10:30 AM IST

Basel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok